AqueSys Microfistula Implant in Refractory Glaucoma

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

April 30, 2015

Conditions
GlaucomaGlaucoma, Open-Angle
Interventions
DEVICE

AqueSys Microfistula Implant

Placement of the AqueSys Microfistula Implant in the study eye

Trial Locations (14)

10003

New York Eye and Ear Infirmary, New York

11714

Eye Care Associates & Glaucoma Consultants of Long Island, Bethpage

22903

UVA Eye Clinic, University of Virginia, Charlottesville

33136

Bascom Palmer Eye Institute, University of Miami, Miami

37232

Vanderbilt Eye Institute, Nashville

55431

Minnesota Eye Consultants, PA, Bloomington

66213

Stiles Eyecare Excellence and Glaucoma Institute, Overland Park

72704

Vold Vision, PLLC, Fayetteville

75231

Glaucoma Associates of Texas, Dallas

78731

Texan Eye, Austin

90033

USC Eye Institute, University of Southern California, Los Angeles

92037

Scripps Clinic, San Diego

99204

Spokane Eye Clinic, Spokane

06824

Ophthalmic Consultants of Connecticut, Fairfield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AqueSys, Inc.

INDUSTRY

NCT01640756 - AqueSys Microfistula Implant in Refractory Glaucoma | Biotech Hunter | Biotech Hunter